Healthcare technology investor Heal Capital has led a series-A funding round for computer-brain-interface specialist CereGate.
SuperAwesome reported revenues of £21m in 2018, as well as an operating loss of £5.5m
GP is deploying equity from its latest fund, EQT IX, which will be 15-20% invested following deal completion
EQT and CDPQ intend to support the company in its growth strategy in France and internationally
Previously, Sygnature has acquired two in-vivo pharmacology clinical research organisations